Literature DB >> 3433287

The respiratory responses of subjects with allergic rhinitis to ozone exposure and their relationship to nonspecific airway reactivity.

W F McDonnell1, D H Horstman, S Abdul-Salaam, L J Raggio, J A Green.   

Abstract

Ozone exposure in man produces changes in respiratory function and symptoms. There is a large degree of unexplained intersubject variability in the magnitude of these responses. There is concern that individuals with chronic respiratory diseases may also be more responsive to ozone than normal individuals. The purpose of this study was to describe the responses of subjects with allergic rhinitis to ozone exposure and to compare these responses to those previously observed in normal individuals. A further purpose was to measure the association of baseline nonspecific airway reactivity with changes in lung function and respiratory symptoms following ozone exposure. A group of 26 nonasthmatic subjects with allergic rhinitis performed a bronchial inhalation challenge with histamine and subsequently underwent two hour exposures to both clean air and to 0.18 part per million ozone with alternating periods of rest and heavy exercise. The airway reactivity of this group of subjects was no greater than that of a comparable group of subjects without allergic rhinitis. The respiratory responses of these subjects to ozone exposure were similar to those previously reported for subjects without allergic rhinitis with the exception that the allergic rhinitis subjects appeared to have a modestly increased bronchoconstrictor response compared to normals. Furthermore, we observed no significant relationships between nonspecific airway reactivity and response to ozone as measured by changes in lung function or the induction of symptoms.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3433287     DOI: 10.1177/074823378700300405

Source DB:  PubMed          Journal:  Toxicol Ind Health        ISSN: 0748-2337            Impact factor:   2.273


  5 in total

1.  Experimental human exposure to air pollutants is essential to understand adverse health effects.

Authors:  William N Rom; Homer Boushey; Arthur Caplan
Journal:  Am J Respir Cell Mol Biol       Date:  2013-11       Impact factor: 6.914

2.  SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans.

Authors:  Aili L Lazaar; Lisa E Sweeney; Alexander J MacDonald; Neil E Alexis; Chao Chen; Ruth Tal-Singer
Journal:  Br J Clin Pharmacol       Date:  2011-08       Impact factor: 4.335

Review 3.  Chemically induced nonspecific bronchial hyperresponsiveness.

Authors:  A Montanaro
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

4.  The role of ozone exposure in the epidemiology of asthma.

Authors:  J R Balmes
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

5.  Identification of subpopulations that are sensitive to ozone exposure: use of end points currently available and potential use of laboratory-based end points under development.

Authors:  R B Devlin
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.